The clinical significance of CHEK2 lies in its role as a tumor suppressor gene. Understanding the status of CHEK2 in tissues can help predict cancer risk and guide therapeutic decisions. For instance, patients with CHEK2 mutations may benefit from increased surveillance for early cancer detection or targeted therapies that exploit the defective DNA repair pathways.